Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Astria Therapeutics, Inc. (ATXS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Morabito Christopher (Chief Medical Officer) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.87, valued at
$387k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| BATE KENNETH (Director) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 8,333 options to buy
@ $2.99, valued at
$24.9k
|
|
| 06/09/2022 |
4
| Violin Jonathan (Director) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 8,333 options to buy
@ $2.99, valued at
$24.9k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Cole Hugh M (Director) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 8,333 options to buy
@ $2.99, valued at
$24.9k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Harshbarger Benjamin (Chief Legal Officer) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.51, valued at
$358.1k
|
|
| 03/03/2022 |
4
| Clauser Noah (CFO) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.51, valued at
$358.1k
|
|
| 03/03/2022 |
4
| Milne Jill C. (CEO and President) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 195,000 options to buy
@ $6.51, valued at
$1.3M
|
|
| 03/03/2022 |
4
| Nichols Andrew John (Chief Scientific Officer) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.51, valued at
$358.1k
|
|
| 03/03/2022 |
4
| Komjathy Andrew (Chief Commercial Officer) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.51, valued at
$358.1k
|
|
| 11/23/2021 |
4
| Komjathy Andrew (Chief Commercial Officer) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Bought 100 shares
@ $6.695, valued at
$669.5 |
|
| 09/22/2021 |
4
| Violin Jonathan (Director) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Disposed of 263,321 shares
@ $0
Acquired 263,321 shares
@ $0 |
|
| 06/10/2021 |
4
| Harshbarger Benjamin (Chief Legal Officer) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $2.16, valued at
$432k
|
|
| 06/02/2021 |
4
| Komjathy Andrew (Chief Commercial Officer) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 600,000 options to buy
@ $0 |
|
| 06/02/2021 |
4
| Nichols Andrew John (Chief Scientific Officer) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 600,000 options to buy
@ $0 |
|
| 06/02/2021 |
4
| Callori Fred (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 85,000 options to buy
@ $2.04, valued at
$173.4k
|
|
| 06/02/2021 |
4
| Violin Jonathan (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 85,000 options to buy
@ $2.04, valued at
$173.4k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| BATE KENNETH (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.04, valued at
$204k
|
|
| 06/02/2021 |
4
| Beck Joanne T. (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.04, valued at
$204k
|
|
| 06/02/2021 |
4
| Milne Jill C. (CEO and President) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 1,400,000 options to buy
@ $0 |
|
| 06/02/2021 |
4
| Cole Hugh M (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.04, valued at
$204k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Harshbarger Benjamin (Senior VP, General Counsel) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 400,000 options to buy
@ $0 |
|
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Callori Fred (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 1,617 options to buy
@ $3009.53, valued at
$4.9M
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|